Journey of medical device development from the bench to the bedside-four real-life examples of commercial biomaterials development

Yves Bayon , Christophe Bureau , Maria J N Perreira , François Aubert , Michel Caillibotte , Robert Vestberg , Didier Letourneur

Exploration of Biomat-X ›› 2024, Vol. 1 ›› Issue (1) : 23 -33.

PDF (2692KB)
Exploration of Biomat-X ›› 2024, Vol. 1 ›› Issue (1) :23 -33. DOI: 10.37349/ebmx.2024.00004
Review
research-article
Journey of medical device development from the bench to the bedside-four real-life examples of commercial biomaterials development
Author information +
History +
PDF (2692KB)

Abstract

Translating biomaterials research into clinical products is a multidisciplinary yet rewarding journey. It should primarily aim to improve patient treatment and clinical outcomes by addressing unmet clinical needs. Four examples of commercial development of biomaterial implants illustrate the diversity of paths, starting from academic research work (AlchiMedics, TISSIUM, Cousin Surgery) or corporate initiatives to develop new products (Medtronic-Sofradim Production). They have been selected from the Translational Research session of the 2022 Conference of the European Society for Biomaterials (ESB) in Bordeaux (France). Commitment, agility, and perseverance were among the key common skills to successfully meet challenges, especially the most unexpected ones. All dimensions of translation projects must be integrated from the start, including the regulatory strategy.

Keywords

Biomaterials / medical devices / translation / clinical development

Cite this article

Download citation ▾
Yves Bayon, Christophe Bureau, Maria J N Perreira, François Aubert, Michel Caillibotte, Robert Vestberg, Didier Letourneur. Journey of medical device development from the bench to the bedside-four real-life examples of commercial biomaterials development. Exploration of Biomat-X, 2024, 1 (1) : 23-33 DOI:10.37349/ebmx.2024.00004

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Ren Y, Fagette PH, Hall CL, Broers H, Grainger DW, Van Der Mei HC, et al. Clinical translation of the assets of biomedical engineering-a retrospective analysis with looks to the future. Expert Rev Med Devices. 2019; 16: 913-22.

[2]

Wang L, Guo X, Chen J, Zhen Z, Cao B, Wan W, et al. Key considerations on the development of biodegradable biomaterials for clinical translation of medical devices: with cartilage repair products as an example. Bioact Mater. 2022; 9: 332-42.

[3]

Asano T, Jin Q, Katagiri Y, Kogame N, Takahashi K, Chang CC, et al. A randomised comparison of healing response between the BuMA Supreme stent and the XIENCE stent at one-month and two-month follow-up: PIONEER-II OCT randomised controlled trial. EuroIntervention. 2018; 14: e1306-15.

[4]

Muñoz Taboada G, Dosta P, Edelman ER, Artzi N. Sprayable hydrogel for instant sealing of vascular anastomosis. Adv Mater. 2022; 34: 2203087.

[5]

Lang N, Pereira MJ, Lee Y, Friehs I, Vasilyev NV, Feins EN, et al. A blood-resistant surgical glue for minimally invasive repair of vessels and heart defects. Sci Transl Med. 2014; 6: 218ra6.

[6]

Pellenc Q, Touma J, Coscas R, Edorh G, Pereira M, Karp J, et al. Preclinical and clinical evaluation of a novel synthetic bioresorbable, on-demand, light-activated sealant in vascular reconstruction. J Cardiovasc Surg (Torino). 2019; 60: 599-611.

[7]

Vermet G, Degoutin S, Chai F, Maton M, Bria M, Danel C, et al. Visceral mesh modified with cyclodextrin for the local sustained delivery of ropivacaine. Int J Pharm. 2014; 476: 149-59.

[8]

Andresen K, Rosenberg J. Management of chronic pain after hernia repair. J Pain Res. 2018; 11: 675-81.

[9]

Chai F, Maton M, Degoutin S, Vermet G, Simon N, Rousseaux C, et al. In vivo evaluation of postoperative pain reduction on rat model after implantation of intraperitoneal PET meshes functionalised with cyclodextrins and loaded with ropivacaine . Biomaterials. 2019; 192: 260-70.

[10]

Miserez M, Jairam AP, Boersema GSA, Bayon Y, Jeekel J, Lange JF. Resorbable synthetic meshes for abdominal wall defects in preclinical setting: a literature review. J Surg Res. 2019; 237: 67-75.

[11]

Witte MB, Barbul A. General principles of wound healing. Surg Clin North Am. 1997; 77: 509-28.

[12]

Clarivate™ [Internet]. MARKET INSIGHTS hernia repair devices, Global; c2023 [cited May 23 2023]. Available from: https://clarivate.com/products/research-reports/report/47041109-medtech-hernia-repair-devices-market-insights-global/

[13]

Mainil-Varlet P, Curtis R, Gogolewski S. Effect of in vivo and in vitro degradation on molecular and mechanical properties of various low-molecular-weight polylactides . J Biomed Mater Res. 1997; 36: 360-80.

[14]

Lasprilla AJ, Martinez GA, Lunelli BH, Jardini AL, Filho RM. Poly-lactic acid synthesis for application in biomedical devices-a review. Biotechnol Adv. 2012; 30: 321-8.

[15]

Palacin S, Bureau C, Charlier J, Deniau G, Mouanda B, Viel P. Molecule-to-metal bonds: electrografting polymers on conducting surfaces. ChemPhysChem. 2004; 5: 1468-81.

PDF (2692KB)

0

Accesses

0

Citation

Detail

Sections
Recommended

/